Nuclear Medicine Market Analysis - Global Industry Size, Share, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Nuclear Medicine
1.1. Definition and Scope 
1.1.1. Definition of Nuclear Medicine
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Nuclear Medicine Market
1.2. Summary
1.2.1. Executive Summary 
1.2.2. Nuclear Medicine Market By Product Type
1.2.3. Nuclear Medicine Market By Application
1.2.4. Nuclear Medicine Market by Regions

CHAPTER 2. Research Approach
2.1. Methodology 
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2 
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Nuclear Medicine Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Nuclear Medicine Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers 
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Nuclear Medicine Market By Product Type
4.1. Introduction
4.2. Nuclear Medicine Revenue By Product Type
4.2.1. Nuclear Medicine Revenue (US$ Mn) and Forecast, By Product Type, 2016-2027
4.2.2. Diagnostic products
4.2.2.1. Diagnostic products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.2.2. SPECT
4.2.2.2.1. TC-99m
4.2.2.2.2. TL-201
4.2.2.2.3. GA-67
4.2.2.2.4. I-123
4.2.2.2.5. Other SPECT products
4.2.2.3. PET
4.2.2.3.1. F-18
4.2.2.3.2. SR-82/RB-82
4.2.2.3.3. Other PET products
4.2.3. Therapeutic Products
4.2.3.1. Therapeutic Products Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3.2.  Alpha Emitters
4.2.3.2.1. RA-223
4.2.3.2.2. Other alpha emitters
4.2.3.3. Beta Emitters
4.2.3.3.1. I-131
4.2.3.3.2. Y-90
4.2.3.3.3. SM-153
4.2.3.3.4. Re-186
4.2.3.3.5. Lu-117
4.2.3.3.6. Other beta emitters
4.2.3.4. Brachytherapy
4.2.3.4.1. Cesium-131
4.2.3.4.2. Iodine-125
4.2.3.4.3. Palladium-103
4.2.3.4.4. Iridium-192
4.2.3.4.5. Other brachytherapy products

CHAPTER 5. Nuclear Medicine Market Revenue By Application
5.1. Introduction
5.2. Nuclear Medicine Revenue (US$ Mn) By Application
5.2.1. Nuclear Medicine Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
5.2.2. Cardiology
5.2.2.1. Cardiology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Neurology
5.2.3.1. Neurology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Oncology
5.2.4.1. Oncology Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.5. Thyroid
5.2.5.1. Thyroid Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.6. Lymphoma
5.2.6.1. Lymphoma Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.7. Bone Metastasis
5.2.7.1. Bone Metastasis Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.8. Endocrine Tumor
5.2.8.1. Endocrine Tumor Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.9. Others
5.2.9.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027

CHAPTER 6. North America Nuclear Medicine Market By Country 
6.1. North America Nuclear Medicine Overview
6.2. U.S.
6.2.1. U.S. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
6.2.2. U.S. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
6.3. Canada
6.3.1. Canada Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
6.3.2. Canada Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
6.4. North America PEST Analysis

CHAPTER 7. Europe Nuclear Medicine Market By Country
7.1. Europe Nuclear Medicine Market Overview
7.2. U.K.
7.2.1. U.K. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.2.2. U.K. Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.3. Germany
7.3.1. Germany Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.3.2. Germany Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.4. France 
7.4.1. France Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.4.2. France Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.5. Spain
7.5.1. Spain Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.5.2. Spain Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.6. Rest of Europe
7.6.1. Rest of Europe Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016-2027
7.6.2. Rest of Europe Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016-2027
7.7. Europe PEST Analysis

CHAPTER 8. Asia Pacific Nuclear Medicine Market By Country
8.1. Asia Pacific Nuclear Medicine Market Overview
8.2. China
8.2.1. China Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.2.2. China Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.3. Japan
8.3.1. Japan Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.3.2. Japan Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.4. India
8.4.1. India Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.4.2. India Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.5. Australia
8.5.1. Australia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.5.2. Australia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.6. South Korea
8.6.1. South Korea Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.6.2. South Korea Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.7. Rest of Asia-Pacific
8.7.1. Rest of Asia-Pacific Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
8.7.2. Rest of Asia-Pacific Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
8.8. Asia Pacific PEST Analysis

CHAPTER 9. Latin America Nuclear Medicine Market By Country
9.1. Latin America Nuclear Medicine Market Overview
9.2. Brazil
9.2.1. Brazil Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.2.2. Brazil Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.3. Mexico
9.3.1. Mexico Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
9.3.2. Mexico Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
9.4. Rest of Latin America
9.4.1. Rest of Latin America Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 – 2027
9.5. Latin America PEST Analysis

CHAPTER 10. Middle East & Africa Nuclear Medicine Market By Country 
10.1. Middle East & Africa Nuclear Medicine Market Overview
10.2. Saudi Arabia
10.2.1. Saudi Arabia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.2.2. Saudi Arabia Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.3. UAE
10.3.1. UAE Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.3.2. UAE Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 - 2027
10.4. Rest of Middle East & Africa
10.4.1. Rest of Middle East & Africa Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Product Type, 2016 - 2027
10.4.2. Rest of Middle East & Africa Nuclear Medicine Market Revenue (US$ Mn) and Forecast By Application, 2016 – 2027
10.5. Middle East & Africa PEST Analysis

CHAPTER 11. PLAYER ANALYSIS OF NUCLEAR MEDICINE
11.1. Nuclear Medicine Market Company Share Analysis
11.2. Competition Matrix
11.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
11.2.2. New Product Launches and Product Enhancements
11.2.3. Mergers And Acquisition In Global Nuclear Medicine Market

CHAPTER 12. COMPANY PROFILE
12.1. Cardinal Health 
12.1.1. Company Snapshot
12.1.2. Business Overview
12.1.3. Financial Overview
12.1.3.1. Revenue (US$ Mn), 2019
12.1.3.2. Cardinal Health  2019 Nuclear Medicine Business Regional Distribution
12.1.4. Product/ Service and Specification
12.1.5. Manufacturing Plant Footprint Analysis
12.2. GE Healthcare 
12.3. Curium 
12.4. Lantheus Medical Imaging 
12.5. Bayer AG 
12.6. Bracco Imaging 
12.7. Eczacibasi-Monrol Nuclear Products 
12.8. Nordion 
12.9. Advanced Accelerator Applications 
12.10. Others